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定了三种 DNA 甲基转移酶家族(DNMTs)，即 DNMT1、DNMT2 和 DNMT3。
DNA 甲基化抑制基因的表达，参与细胞的多种生理活动，在基因突变、基因表
达调控、细胞增殖、分化、发育、基因印记等方面起着重要作用。近来的研究发
现，人体细胞中 EZH2 和 DNMTs 在功能上相关。研究证实 EED-EZH2 复合物能
特异性的甲基化组蛋白 H3 的 27 位赖氨酸(H3K27)，包括 EZH2 在内的 PRC 亚
单位和人体三种 DNMTs 发生免疫共沉淀，而且特定靶基因的沉默需要 EZH2 和




肺上皮细胞或肺癌细胞增殖、迁移等细胞表型的改变，同时 EZH2 和 DNMT1 的
表达量也明显上调，且在一定范围内呈现出剂量和时间依赖性的特点；以 DNA
甲基化酶抑制剂处理或干扰 EZH2 的表达，均可抑制上述细胞表型；进一步干扰
















EZH2 和 DNMT1 的上调实现的，同时提示 nAChRs 基因的活化可能介导肺癌发
生中表观遗传学修饰的变化。进一步的研究提示，尼古丁引起的 EZH2 和 DNMT1
的上调部分是由 PI3K/AKT 信号通路介导的。 











































Bronchial carcinoma short-named lung cancer, is a main malignant tumor in  
cancer spectrum Epidemiological survey showed that somking is closely related to the 
lung cancer,confirming that smoking is one external factor causing lung cancer. 
Smoking process can produce 40 kinds of carcinogens,and nicotine is closely related 
to lung cancer.Nicotine is a small molecule organic alkaloids.The study suggests that 
nicotine can activate nicotinic acetylcholine receptors (nAChRs) and then regulate the 
the intracellular signaling responses,effecting transcription factors,regulating gene 
expression,cell proliferation,differentiation and migration.Cancer.diabetes,Artz 
Alzheimer disease and other diseases are closely related to nicotine.  
Epigenetic mechanisms in the pathogenesis of cancer has important position as 
well as gene mutation.DNA and histone modifications are important epigenetic 
mechanism involved in regulating many biological events,considered with many 
cancer development.Presently it has identified three types of DNA methyltransferase 
family in mammalian;DNMT1,DNMT2 and DNMT3.In general,DNA methylation 
can inhibit gene expression.A variety of physiological activities in cells,such as gene 
mutation,gene regulation,cell proliferation,differentiation,development and genomic 
imprinting play an important role. Recent studies have found that EZH2 is 
functionally related to DNA methyltransferase.It was proved that EED-EZH2 
complexes to specific methylation of histone H3 nucleosomes lysine 27 (H3K27), 
including the PRC, including EZH2 subunit and human DNA methyltransferase 
occurs immunoprecipitation.The particular target gene silence needs both DNA 
methyltransferase and EZH2 participation. Studies have found that the process of 
tumor associated with gene methylation and then turn into complete silence. 
Methylation in tumors play an important role,but little is konwns about lung cancer 















This study,using normal lung and lung cancer,detected that nicotine can 
significantly enhanced cell phenotype such as cell proliferation and 
migration.EZH2,DNMT1 expression was significantly increased showing a dose-and 
time-dependent features.DNA methyltransferase inhibitors or interfering cells 
EZH2,could significantly inhibit the cell phenotype.Nicotine stimulation does not 
cause upregulation of EZH2 and DNMT1 in nAChR α7 shRNA,suggesting that 
nicotine induced the change of lung cancer cell phenotype is mediated through 
nAChRs. Further studies suggest that nicotine-mediated changes in EZH2 and 
DNMT1 parlyt by the PI3K/AKT signaling pathway. 
This study confirmed that the nicotine effected EZH2 and DNMT1 expression 
mediated by nAChRs in lung cancer. It provided a new way to clarify the mechanism 
of nicotine in lung cancer and find a potential new target for cancer prevention. 
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肺癌(Non Small Cell Lung Cancer, NSCLC)和小细胞肺癌(Small Cell Lung Cancer, 
SCLC)。二者的生长和扩散方式均不同，治疗方法及预后也明显不同，SCLC 约
占肺癌的 20%，增长迅速，容易转移到身体其它部位。NSCLC 占肺癌总数的
75%-80%，根据组织学表现又可分为：鳞状细胞癌(Squamous Cell Carcinoma, 
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